Geoffrey A Donnan Selected Research

Geoffrey A Donnan Research Topics

Disease

152	Stroke (Strokes) 02/2022 - 01/2002
103	Ischemic Stroke 02/2022 - 01/2002
27	Infarction (Infarctions) 01/2022 - 01/2002
13	Hemorrhage 03/2022 - 01/2010
9	Cerebral Hemorrhage 03/2022 - 06/2006
8	Hypertension (High Blood Pressure) 01/2022 - 02/2002
8	Cerebral Infarction 01/2020 - 01/2002
7	Atrial Fibrillation 10/2019 - 04/2002
6	Hematoma 03/2022 - 11/2013
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 09/2002
6	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2017 - 09/2008
5	Brain Edema (Cerebral Edema) 01/2022 - 08/2013
5	Edema (Dropsy) 01/2022 - 08/2013
5	Ischemia 08/2018 - 05/2004
4	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2022 - 01/2014
4	Dementia (Dementias) 01/2021 - 10/2004
4	Brain Ischemia (Cerebral Ischemia) 05/2012 - 01/2008
3	Carotid Stenosis (Carotid Artery Stenosis) 10/2019 - 01/2004
3	Body Weight (Weight, Body) 01/2018 - 03/2015
3	Transient Ischemic Attack 01/2017 - 05/2012
3	Cognitive Dysfunction 01/2017 - 10/2008
3	Hypoxia (Hypoxemia) 03/2011 - 07/2006
2	Thrombosis (Thrombus) 05/2019 - 01/2018
2	Inflammation (Inflammations) 01/2016 - 01/2006
2	Embolism (Embolus) 05/2014 - 04/2012
2	Hypothermia 08/2013 - 12/2007
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2011 - 09/2003
1	COVID-19 05/2022
1	Hemorrhagic Stroke 01/2021
1	Frailty 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Wounds and Injuries (Trauma) 12/2020
1	Intracranial Thrombosis (Cerebral Thrombosis) 01/2020
1	Neurologic Manifestations (Neurological Manifestations) 01/2019
1	Hyperglycemia 01/2019
1	Neoplasms (Cancer) 10/2018

Drug/Important Bio-Agent (IBA)

61	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 01/2005
18	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 05/2004
15	Tenecteplase FDA Link 01/2022 - 01/2014
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2004
9	Neuroprotective AgentsIBA 08/2018 - 05/2004
8	Pharmaceutical PreparationsIBA 08/2018 - 05/2004
6	Cytidine Triphosphate (CTP)IBA 10/2018 - 01/2008
6	Warfarin (Coumadin)FDA LinkGeneric 05/2014 - 05/2004
5	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 08/2013
5	Biological ProductsIBA 01/2020 - 03/2009
5	fluoromisonidazoleIBA 03/2011 - 02/2004
4	Tranexamic Acid (AMCA)FDA Link 03/2022 - 06/2014
4	CholesterolIBA 10/2019 - 02/2002
4	Clopidogrel (Plavix)FDA Link 05/2014 - 11/2004
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2022 - 06/2011
3	Indicators and Reagents (Reagents)IBA 01/2020 - 08/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 12/2014
3	disufenton sodium (NXY 059)IBA 08/2018 - 08/2006
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2008
3	Angiotensin Receptor AntagonistsIBA 09/2009 - 09/2008
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2015
2	Complement System Proteins (Complement)IBA 01/2020 - 01/2016
2	LipidsIBA 01/2018 - 01/2012
2	ORALIT (ORS)IBA 07/2017 - 06/2005
2	Glyburide (Glibenclamide)FDA LinkGeneric 08/2014 - 01/2014
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 05/2012 - 12/2010
2	Amyloid (Amyloid Fibrils)IBA 05/2012 - 12/2010
2	Desmodus rotundus salivary plasminogen activator alpha 1IBA 01/2010 - 03/2009
2	Dipyridamole (Persantine)FDA LinkGeneric 10/2008 - 09/2008
2	Telmisartan (Micardis)FDA Link 10/2008 - 09/2008
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 05/2008 - 01/2008
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2008 - 04/2002
2	Perindopril FDA LinkGeneric 06/2003 - 02/2003
2	Heparin (Liquaemin)FDA LinkGeneric 04/2003 - 01/2003
1	FibrinIBA 05/2022
1	GadoliniumIBA 01/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2022
1	VitronectinIBA 01/2020
1	ClusterinIBA 01/2020
1	Complement C9 (Complement Component 9)IBA 01/2020
1	Edetic Acid (EDTA)FDA Link 01/2020
1	Dabigatran FDA Link 01/2019
1	idarucizumabIBA 01/2019
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 08/2018
1	Oxygen (Dioxygen)IBA 08/2018

Therapy/Procedure

69	Therapeutics 02/2022 - 01/2002
32	Thrombectomy 02/2022 - 03/2015
13	Thrombolytic Therapy 06/2016 - 11/2002
9	Secondary Prevention 10/2019 - 02/2003
6	Stents 01/2019 - 03/2015
5	Carotid Endarterectomy 10/2019 - 08/2002
5	Treatment Delay 05/2017 - 04/2014
4	Contraindications 01/2020 - 10/2017
4	Time-to-Treatment 05/2019 - 05/2010
3	Aftercare (After-Treatment) 01/2019 - 07/2013
3	Institutionalization (Institutionalized Persons) 10/2004 - 12/2002
2	Length of Stay 01/2021 - 04/2003
2	Patient Readmission 12/2020 - 07/2015
2	Early Ambulation 11/2020 - 01/2011
2	Catheters 01/2020 - 01/2018
1	Critical Care (Surgical Intensive Care) 09/2021
1	Subacute Care 12/2020
1	Punctures 01/2019
1	Embolectomy 10/2018